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Abstract The affinity of four short peptides for the Escherichia
coli molecular chaperone GroEL was studied in the presence of
the co-chaperone GroES and nucleotides. Our data show that
binding of GroES to one ring enhances the interaction of the
peptides with the opposite GroEL ring, a finding that was related
to the structural readjustments in GroEL following GroES
binding. We further report that the GroEL/GroES complex has a
high affinity for peptides during ATP hydrolysis when protein
substrates would undergo repeated cycles of assisted folding.
Although we could not determine at which step(s) during the
cycle our peptides interacted with GroEL, we propose that
successive state changes in GroEL during ATP hydrolysis may
create high affinity complexes and ensure maximum efficiency of
the chaperone machinery under conditions of protein folding.
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1. Introduction
The Escherichia coli molecular chaperone GroEL and its
co-chaperone GroES are the most widely studied members
of the molecular chaperone family of proteins whose function
is to assist the folding and refolding of substrate proteins [1^
3]. The combination of the GroEL/GroES/ADP7 crystal struc-
ture [4] and numerous elegant physical studies using GroEL
mutants [5^8] now provides convincing evidence as to how the
interaction between GroEL, GroES and nucleotides leads to
the controlled cyclical sequestration of substrate protein fold-
ing intermediates. This complex reaction cycle of protein fold-
ing has been described as a two-stroke folding machine [3,9]
and is comprised of several steps (for a recent review see [2]).
Brie£y, the initial recognition and binding of a non-native
protein at a GroES-free ring is followed by the release of
the bound polypeptide into the central cavity which is formed
through the binding of GroES and ATP at the same ring. The
protein substrate is allowed to equilibrate inside this protected
environment (sometimes known as An¢nsen’s cage) for a ¢xed
amount of time whilst ATP is being hydrolysed to ADP (t1=2
6^8 s) [6,10,11]. A further step of ATP binding at the opposite
or trans ring leads to the discharge of GroES, ADP and the
substrate which may now be in a form that is disposed to-
wards productive folding. In vitro studies with proteins sug-
gest that the nucleotide-free ring with GroES and ADP bound
in trans represents the acceptor state for substrates [4,5,12].
During its reaction cycle, the chaperone undergoes several
combinations of GroES, ATP and ADP bound to its two
rings, and it is therefore likely that a non-native protein
may encounter, and possibly bind to, all or some of these
states with varying strength. The actual substrate a⁄nity of
the GroEL ring in trans to GroES and its occupancy with
nucleotides during in vivo folding conditions remain some-
what ill-de¢ned at present.
For most protein substrates, reaching a native-like state
that is no longer recognised by the chaperonin involves
many iterative cycles of rebinding and release [13^16]. These
structural rearrangements result in successive changes in the
a⁄nity of these protein substrates for GroEL and make it
di⁄cult to assess the a⁄nity of the GroEL/GroES folding
machinery during protein folding conditions, i.e. during cycles
of ATP hydrolysis and repeated substrate release. Using pep-
tide substrates as mimetics of non-native proteins has the
advantage that this approach circumvents complications
through kinetic competition between substrate folding and
binding. Consequently, the a⁄nity of the GroEL/GroES ma-
chinery under protein folding conditions may be studied more
readily. In our previous e¡orts to describe the phenomenon of
molecular recognition and substrate binding by GroEL, we
have employed short peptides and looked at the e¡ects of
primary and secondary structure on binding by GroEL
[17,18]. Since in the cellular environment, GroEL functions
in synergy with its co-chaperone GroES and in the presence
of nucleotides, we report in this study the results of experi-
ments designed to describe the a⁄nity of the complete
GroEL/GroES machinery. The NON-AMPH series of pep-
tides used in this study was originally designed to probe the
importance of non-amphiphilic secondary structure to GroEL
molecular recognition and substrate binding, and comprises
three peptides (sequence: ALYKIKKIKLLESK-O-dansyl)
where one was N-terminally modi¢ed with an K-helix stabilis-
ing template (NON-AMPH), one was modi¢ed with a non-
stabilising template (NON-AMPH3), and one was left un-
modi¢ed (NON-AMPHR) [17]. These three £uorescent pep-
tides and the parent peptide Bamph (sequence: dansyl-PLYK-
KIIKKLLES) were shown previously to display strong
a⁄nities for GroEL with apparent dissociation constants in
the nM to WM region (cf. [17,18] and Fig. 1A). In this paper
we present the results of experiments designed to describe the
e¡ects of GroES and nucleotides such as ATP and ADP on
the a⁄nity of GroEL for peptides.
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2. Materials and methods
2.1. Protein and peptide preparation
GroEL and GroES were puri¢ed from a recombinant strain of
E. coli according to previously published methods [17,19]. The protein
concentrations given always refer to the oligomer concentration. The
peptides (NON-AMPH, NON-AMPH3, NON-AMPHR and Bamph)
were prepared as described previously [17,18].
2.2. Fluorescence binding assays
Fluorescence GroEL^peptide equilibrium binding assays were per-
formed as described previously [17]. Brie£y, pre-equilibrated peptide
solutions (1.0 WM) were titrated with GroEL or equimolar amounts of
GroEL and GroES (in 50 mM Tris^HCl pH 7.6, 2 mM dithiothreitol)
until the £uorescence intensity enhancement appeared to be saturat-
ing. Given concentrations refer to the GroEL concentration. At each
addition, the dansyl £uorescence emission intensities at 500 nm (ex-
citation at 350 nm), corrected for protein background, were tabulated
and the intensity of free peptide was subtracted in order to give the
£uorescence intensity enhancement, vI500. vI500 data were then ana-
lysed as a function of the GroEL concentration using a model for
binding in which a given peptide was assumed to be able to interact
with an unspeci¢ed number of independent binding sites on the
GroEL homo-oligomer [18]:
vI500  vP PtGt=Kd  Gt 1
where [P]t is the total peptide concentration (1 WM), [G]t the total
GroEL concentration, Kd the apparent dissociation constant, and vP
a term deriving from the £uorescence quantum yield enhancement
upon peptide binding to GroEL.
Binding assays were performed in bu¡er A (50 mM Tris^HCl pH
7.6, 2 mM dithiothreitol), bu¡er B (bu¡er A, 10 mM KCl, 10 mM
MgCl2), ADP bu¡er (bu¡er B, 8 mM ADP), and ATP bu¡er (bu¡er
B, 8 mM ATP) with either GroEL or equimolar amounts of GroEL
and GroES at 20‡C. A concentration of 8 mM ATP was chosen to
ensure on-going hydrolysis over the time course of the titration experi-
ment (approximately 1 h), and to minimise product inhibition by
ADP.
3. Results
3.1. Binding in the absence of GroES
Fig. 1A shows the dissociation constants of interaction of
the four peptides with GroEL. Strongest binding was found
under conditions of low ionic strength in our standard assay
bu¡er A. Consistent with previous results [17], the a⁄nity of
the complex was substantially weakened in bu¡er B where
magnesium and potassium ions were included to obtain con-
ditions allowing ATP hydrolysis for later experiments [20,21].
This decrease in a⁄nity is likely to be due to shielding of
favourable electrostatic attractions between the negatively
charged GroEL protein [22] and the positively charged pep-
tides by salts [17].
The presence of ATP was found to lower the a⁄nity of
GroEL for the peptides signi¢cantly, a ¢nding that is consis-
tent with the literature [23^25]. Nucleotide binding to GroEL
occurs in a co-operative manner involving one ring at a time
[26^28], and is known to induce conformational changes
[4,5,24,29^31] where the nucleotide-free ring (T-state) and
the nucleotide-bound ring (R-state) display a high and low
a⁄nity for substrate proteins respectively [26,27]. The a⁄nity
of the GroEL/ADP complex for the peptides (static situation)
was found to be enhanced relative to the dynamic situation
under conditions of ATP hydrolysis. This ¢nding is consistent
with the fact that GroEL displays weaker binding for ADP
relative to ATP [32,33], and that higher concentrations of
ADP are required for the transition of high to low a⁄nity
complexes [12].
3.2. Binding in the presence of GroES
Fig. 2 shows representative isotherms for binding of the
NON-AMPH peptide under conditions where both GroEL
and GroES were present in the reaction mixture. The resulting
dissociation constants for all peptides are illustrated in Fig.
1B. The presence of a twofold excess of GroES over GroEL
was found not to alter peptide binding to GroEL by more
than the experimental error (bu¡er A, not shown). This con-
¢rmed that the peptides did not interact strongly with free
GroES [17].
Fig. 1B shows that the a⁄nity of GroEL/GroES complexes
for peptides under conditions of protein folding (dynamic sit-
uation, ATP bu¡er) was raised slightly above the a⁄nities of
the static complexes, the nucleotide-free state (bu¡er B) and
the resting complex (ADP bu¡er), generally thought to be the
acceptor state for substrate proteins (cf. complex 1 in Scheme
1) [4,5,12]. This contrasts with results presented in Fig. 1A
where ATP was found to weaken the a⁄nity throughout.
4. Discussion
4.1. Binding to GroEL only
The allosteric readjustments that occur as a consequence of
the binding of nucleotides to GroEL control the a⁄nity of a
GroEL ring for substrate proteins/peptides [12]. Recent cryo-
electron microscopy images of GroEL provide insight into the
structural changes involved [1,29^31]. Nucleotide binding to
one GroEL ring has been shown to disrupt the continuity of
the binding surface of this ring (R-state), thereby lowering its
accessibility and a⁄nity for polypeptide chains. Slight changes
also occur at the opposite T-state ring, which appears verti-
Fig. 1. A: Column chart of dissociation constants (Kd) on interac-
tion of peptides with GroEL (WM). B: Column chart of dissociation
constants (Kd) on interaction of peptides with GroEL:GroES = 1:1
(WM). Error margins in both panels were derived from the S.E.M.s
of the binding isotherms.
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cally extended but closed by an inward twist in a clockwise
rotation. Overall, this leads to a progressive elongation of the
structure upon the transition from the nucleotide-free TT-
state to the TR-state at low concentrations of nucleotide
and the RR-state at high concentrations of nucleotide
[12,27,29]. These structural changes may explain the hierarchy
of the decrease in a⁄nity shown in Fig. 1A. The fact that the
nucleotide-free GroEL ring was found to display the highest
a⁄nity for substrates, followed by an ADP-liganded, and then
the ATP-bound conformation, has also been reported else-
where [25,26].
A concern raised with many in vitro studies is the concen-
tration of nucleotide which is generally much lower than what
would be expected in vivo. The nucleotide concentrations
chosen in this study were physiological with respect to ATP
in the cell (8 mM), but unusually high with regards to ADP in
E. coli (1 mM) [34]. Another concern is the physiological
relevance of the allosteric transitions of GroEL that take place
in vitro at ATP concentrations much lower than those in
E. coli [35]. The concentrations of ATP and ADP where the
transition from asymmetric to symmetric nucleotide-bound
complexes takes place, as well as the possibility that GroES
may modulate the occupancy of GroEL with nucleotide, are
not yet fully de¢ned [6,8,12,27,36]. It is likely, however, that
mostly symmetric complexes were present under our experi-
mental conditions.
4.2. GroES enhances peptide binding to GroEL
GroEL and GroES are thought not to associate very tightly
in the absence of nucleotides [12,32,36,37] (bu¡er A), although
these complexes may form more readily in bu¡er B for rea-
sons of salt shielding of electrostatic repulsion between the
two acidic proteins [22]. Given the fact that the peptide bind-
ing sites of GroEL are well known to double up as GroES
binding sites [38^41], GroEL/GroES complexes, once formed,
are likely to o¡er only half of the binding regions [17]. This
would approximately double the value of the peptides’ appar-
ent dissociation constants provided that binding of GroES in
trans does not a¡ect the a⁄nity of the binding-competent
ring. Fig. 1B shows that the binding of peptides to complexes
of GroEL and GroES was stronger than in the absence of
GroES under the same experimental conditions (Fig. 1A).
The e¡ect of GroES to enhance peptide binding agrees with
an increase in a⁄nity of GroEL for nucleotides in the pres-
ence of the co-chaperonin and vice versa [12,20,32,33,37].
Taken together these ¢ndings would appear to suggest that
GroES acts as a co-operative organiser by increasing the af-
¢nity of the complex not only for nucleotides, but also for
substrates at the opposite ring.
Changes in a⁄nity may be explained by the crystal struc-
ture of the GroEL/GroES/ADP complex [4]. Binding of the
co-factors to one GroEL ring was shown to result in struc-
tural readjustments which are compensated for by movements
of the trans ring where they cause an outward tilt that has
been thought responsible for the opposed binding of a second
GroES [4]. It seems attractive to speculate that this outward
tilt may result in conformational changes in the binding sites
which altered, possibly increased, the a⁄nity of GroEL for
our peptides when compared to the inward twist and closing
of the ring upon ATP binding in the absence of GroES [29].
4.3. Binding to GroEL/GroES/nucleotide complexes
In the presence of ADP, GroEL and GroES associate very
tightly with microscopic dissociation constants in the low nM
region [12,20,32,33,36,37], forming a static nucleotide-bound
complex in which GroES does not exchange during a time
course of hours if ATP is not present (complex 1, Scheme
1) [12,36]. This contrasts with the dynamic situation in ATP
Fig. 2. Representative binding isotherms for binding of the NON-
AMPH peptide to GroEL/GroES complexes. The £uorescence in-
tensity enhancement vI500 is shown as a function of the GroEL con-
centration. The curves through the data sets are ¢ts to the binding
model (Eq. 1), the calculated values for the dissociation constants
are shown in Fig. 1B. Binding in bu¡er A (a), bu¡er B (b), ADP
bu¡er (P), and ATP bu¡er (8).
Scheme 1. Schematic model for the reaction cycle of GroEL and
GroES, adapted from Horwich and co-workers [4^6] and borrowing
from the notation of Sparrer and Buchner [12]. Our results suggest
the creation of complexes of high a⁄nity during the slow step of
ATP hydrolysis (2 to 3 and 4 to 5) where GroEL may undergo up
to seven co-operative state changes [26,27]. Peptide may bind with
low a⁄nity to the ATP-bound complex (2 and 4) [5], but de¢nitely
enters the complex before the formation of the ADP form (3 and
5). The a⁄nities of complexes 3 and 5 are probably identical to the
medium a⁄nity of the resting state 1 (Fig. 1B). Fluorescent peptide
inside the cavity is assumed to be spectroscopically indistinguishable
from peptide in the bulk solution.
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bu¡er where ternary complexes associate and dissociate rap-
idly after hydrolysis, and where, every 15 s or so, sites avail-
able for peptide binding may switch between the two GroEL
rings [3^6,42]. This cycle and possible points of entry for
peptide are depicted in Scheme 1. The a⁄nity of the resting
complex 1 was determined to be of medium strength (ADP
bu¡er) and is probably identical to the a⁄nity of the transi-
ently occurring complexes 3 and 5. As to the a⁄nity of the
ATP-bound complex (2 and 4), a recent study by Rye et al.,
using the hydrolysis-de¢cient GroEL mutant D389A, sug-
gested that hydrolysis of ATP must occur before a non-native
polypeptide and GroES can bind to the opposite ring [5]. This
result has been related to slight di¡erences in cryo-electron
microscopy images of the trans ring of ATP-bound (2 and
4) compared to ADP-bound (3 and 5) GroEL/GroES com-
plexes. A slight rotation of the binding sites appears to reduce
the accessibility of the binding sites and is probably respon-
sible for the low binding a⁄nity of the ATP-bound complex
[5].
The discussion of results obtained during ATP hydrolysis,
where available binding sites alternate between both rings
(Scheme 1), is more controversial than the static situation in
ADP bu¡er (or using D389A) where peptide binding was
probably con¢ned to one ring. Our result of a relatively
high a⁄nity complex for peptides under dynamic conditions
of ATP hydrolysis is somewhat astonishing, particularly since
static ATP-bound and ADP-bound complexes were found to
display only low [5] and moderate a⁄nities respectively (Fig.
1B). This appears to contrast with a⁄nity studies in the ab-
sence of GroES where ATP was found to lower the a⁄nity
(Fig. 1A) and suggests that the interaction of the peptides
with GroEL is co-ordinated by GroES. Studies of the reaction
cycle show that the conversion of complex 2 to 3 (and 4 to 5)
is the slowest step in the cycle and is regulated by the co-
operative hydrolysis of seven ATP molecules with a half-
time of 6^8 s [5,6,26,27]. In interpreting our results we would
like to put forward the suggestion that this conversion of
GroEL/GroES/ATP7 to GroEL/GroES/ADP7 complexes
leads to co-operative state changes in GroEL and the forma-
tion of up to seven transiently occurring intermediates, some
or all of which must have a high a⁄nity for peptides. This
results in a dynamic complex which displays an a⁄nity greater
than that of the ATP-bound complex [5] and slightly greater
than that of the ADP-bound state (Fig. 1B). We cannot rule
out the possibility that state transitions during the conversion
of complex 3 to 4 (and 5 to 2) may also contribute to the
binding as our assay only measures the sum of all interac-
tions. However, taking into account that these conversions
take place at the di¡usion-controlled limit (compared to
the slow steps of hydrolysis), in our view, it is unlikely
that these intermediates contribute signi¢cantly to the overall
a⁄nity.
5. Conclusions
Previous reports on the refolding of protein substrates in
the presence of ATP reported a loss of a⁄nity between the
chaperone and substrate proteins [12,23^25]. However, under
these folding conditions, protein substrates are likely to expe-
rience a loss of binding-competent surfaces with each cycle of
substrate binding, folding in the cavity, and release. The use
of short peptides as mimetics of denatured proteins circum-
vents this complication of kinetic competition between sub-
strate folding and binding and allows investigation into equi-
librium binding during ATP hydrolysis.
Our data, presented in Fig. 1B, provide evidence for a high
a⁄nity state of peptide substrate binding of the chaperone
machinery during protein folding conditions. By extrapola-
tion, it would appear likely that the same may be true for
protein substrates although their a⁄nity may not be studied
so readily. We cannot determine exactly at which step(s) dur-
ing this dynamic cycle our peptides interacted with GroEL,
but our data suggest that GroEL may undergo a number of
co-operative state changes with high peptide a⁄nity during
the slow hydrolysis of the seven GroEL-bound ATP mole-
cules. This result may be intuitively acceptable bearing in
mind that many GroEL oligomers undergo this rate-determin-
ing conversion at any one time. To us, the reaction cycle
would appear less e⁄cient if these states did not have the
ability to stabilise protein intermediates at the opposite ring.
A similar reasoning may be given to explain the slightly lower
a⁄nity of the ADP-bound resting complex which is most
likely the predominant conformation in the cell under stress
conditions, for example through heat shock [12,32,33]. Under
these conditions, the GroEL cycle is slowed because of the
accumulation of ADP [42,43], although temperature-induced
conformational changes in GroEL may also play a role [44]. It
seems attractive to speculate that the resting complex may
provide a means for GroEL to stabilise large amounts of
unfolded proteins in the cell until the ATP/ADP ratio is re-
stored, no further unfolding occurs and tight binding during
hydrolysis is necessary to restore the productivity of the re-
folding cycle by minimising non-productive losses of bound
polypeptide into the bulk solution.
Our study using wild-type GroEL and GroES and physio-
logical concentrations of ATP demonstrated a high a⁄nity of
the chaperone machinery for peptides under protein folding
conditions. This result raises the possibility that successive
structural readjustments during ATP hydrolysis create high
a⁄nity states of GroEL for substrates, and therefore comple-
ments results of experiments that describe the a⁄nity of
GroEL complexes under static conditions [5]. It will be a
challenge for further investigations to corroborate this hy-
pothesis and demonstrate the existence of successive state
and a⁄nity changes in GroEL during hydrolysis.
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